- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (68)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (26)
- Bladder Cancer (72)
- Brain Metastases (28)
- Brain Tumor (230)
- Breast Cancer (720)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (158)
- Colon Cancer (164)
- Colorectal Cancer (114)
- Endocrine Tumor (4)
- Esophageal Cancer (44)
- Eye Cancer (36)
- Fallopian Tube Cancer (8)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (8)
- Kidney Cancer (126)
- Leukemia (344)
- Liver Cancer (50)
- Lung Cancer (288)
- Lymphoma (284)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (98)
- Myelodysplastic Syndrome (60)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (100)
- Ovarian Cancer (172)
- Pancreatic Cancer (164)
- Parathyroid Disease (2)
- Penile Cancer (14)
- Pituitary Tumor (6)
- Prostate Cancer (144)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (238)
- Skin Cancer (296)
- Skull Base Tumors (56)
- Spinal Tumor (12)
- Stomach Cancer (62)
- Testicular Cancer (28)
- Throat Cancer (92)
- Thymoma (6)
- Thyroid Cancer (96)
- Tonsil Cancer (30)
- Uterine Cancer (80)
- Vaginal Cancer (16)
- Vulvar Cancer (20)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (10)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (632)
- Complementary Integrative Medicine (24)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (230)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (124)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (118)
- Molecular Diagnostics (8)
- Pain Management (62)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (912)
- Research (396)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (608)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (402)
- Survivorship (322)
- Symptoms (184)
- Treatment (1788)
The waiting game: A cancer survivor's story
BY Marcy Kurtz
3 minute read | Published July 16, 2013
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on July 16, 2013
Perhaps you've heard the expression "too much time to do nothing, not enough time to do anything." It is one of my favorites.
I am not fond of being idle. On the other hand, I do not like being rushed when I have a task to accomplish. Not having enough time to do anything and having too much time to do nothing leaves me in a state of complete frustration because I am in limbo. When I am in limbo, I feel out of control. Feeling out of control makes me feel powerless.
Being a cancer survivor sometimes creates these same feelings of frustration, lack of control and powerlessness.
A longer reprieve from scans and scanxiety after uterine cancer
I completed nine months of treatment for uterine cancer at the end of March 2011. I have remained under the watchful eye of my team at MD Anderson since then.
Because of the aggressive nature of my uterine cancer and the particulars of my uterine cancer diagnosis, my team determined I should have quarterly PET scans and follow-up doctor visits. In March 2013, my team and I determined that I could "graduate" to tests every four months. I was relieved to get a longer reprieve between scans and the stress associated with getting tested for any evidence of cancer.
Importantly, I also interpreted that one-month extension to be a sign that my team believed my long term prognosis was improving. I finally did not need to be as closely monitored. I had passed my critical two-year mark with no evidence of recurrence. I was ecstatic.

I have learned during my cancer journey not to ever waste time.
Marcy Kurtz
Survivor